low-to-moderate - Hospital utilization is relatively recession-resistant due to non-discretionary medical needs, but elective procedures and patient volumes can decline during economic downturns, pressuring tenant cash flows. Medicare/Medicaid reimbursement rates (linked to government budgets) and labor costs (nursing shortages) create indirect cyclical exposure. The 14.2% revenue growth suggests portfolio expansion rather than organic growth.

Rising rates create multiple headwinds: (1) Higher borrowing costs on the $13B+ debt stack reduce cash available for dividends, (2) REIT valuations compress as 10-year Treasury yields rise (dividend yields must compete with risk-free rates), (3) Cap rates on hospital acquisitions increase, reducing property values and creating mark-to-market losses. The 36.4x EV/EBITDA suggests the market is pricing in significant earnings normalization. Floating-rate debt exposure amplifies sensitivity to Fed policy.

value/distressed - The 0.7x price-to-book and 34% six-month recovery suggests deep-value investors betting on Steward resolution and portfolio stabilization. High historical dividend yield (though sustainability questioned) attracts income-focused investors willing to accept elevated risk. Not suitable for growth investors given mature REIT model and portfolio challenges. The -14.8% ROE and negative net income deter quality-focused value investors.